Abiopharma

News list

(80% Positive) ATAI LIFE SCIENCES N.V. (ATAI) Provides Update on supported for his transition by current CFO Greg Weaver

Full text

News bot Oct. 2, 2025, 8:07 a.m.
📋 ATAI LIFE SCIENCES N.V. (ATAI) - Clinical Trial Update

Filing Date: 2022-06-17

Accepted: 2022-06-17 08:12:55

Event Type: Clinical Trial Update
Event Details:
ATAI Life Sciences (ATAI) Announces Clinical Trial Update ATAI Life Sciences (ATAI) provided an update on its clinical development programs. Clinical Development Highlights:
Drug Program: supported
Diseases/Conditions: his transition by current CFO Greg Weaver, our team
Collaboration: Co-Founder
Updated Timeline: March 31, 2023
💼 Business Developments:

No business developments data available.
Structured Data:
- Company Name: ATAI Life Sciences
- CIK: 0001840904
- Ticker Symbol: ATAI
- Period End Date: 2022-06-15
- Document Type: 8-K